1. Home
  2. MYGN vs SPT Comparison

MYGN vs SPT Comparison

Compare MYGN & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$4.28

Market Cap

444.2M

Sector

Health Care

ML Signal

N/A

SPT

Sprout Social Inc

N/A

Current Price

$7.29

Market Cap

449.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
SPT
Founded
1991
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
449.6M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
MYGN
SPT
Price
$4.28
$7.29
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$7.64
$11.75
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.11
EPS
N/A
N/A
Revenue
$771,400,000.00
$457,547,000.00
Revenue This Year
$6.86
$8.86
Revenue Next Year
$5.45
$8.04
P/E Ratio
N/A
N/A
Revenue Growth
2.33
12.72
52 Week Low
$3.53
$4.92
52 Week High
$8.59
$21.53

Technical Indicators

Market Signals
Indicator
MYGN
SPT
Relative Strength Index (RSI) 48.53 56.15
Support Level $3.53 $5.94
Resistance Level $5.30 $7.45
Average True Range (ATR) 0.32 0.45
MACD 0.02 -0.04
Stochastic Oscillator 42.70 39.44

Price Performance

Historical Comparison
MYGN
SPT

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.

Share on Social Networks: